These findings suggest that IL-4 serves as a metabolic regulator, linking eosinophils, AT, and leptin levels, making it a potential therapeutic candidate for obesity and its complications by regulating hyperleptinemia [50]. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.